Thermo Fisher Scientific Inc. Share Price Lima
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
596.3 USD | +1.93% | 0.00% | +13.20% |
10/05 | UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger | MT |
10/05 | UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink | MT |
Sales 2024 * | 4.3TCr 3,58900Cr | Sales 2025 * | 4.61TCr 3,84500Cr | Capitalization | 23TCr 18,94700Cr |
---|---|---|---|---|---|
Net income 2024 * | 611.1Cr 51TCr | Net income 2025 * | 700.1Cr 58TCr | EV / Sales 2024 * | 5.84 x |
Net Debt 2024 * | 2.4TCr 2,00200Cr | Net Debt 2025 * | 1.92TCr 1,60100Cr | EV / Sales 2025 * | 5.34 x |
P/E ratio 2024 * |
37.6
x | P/E ratio 2025 * |
32
x | Employees | 1,22,000 |
Yield 2024 * |
0.25% | Yield 2025 * |
0.27% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific Inc.
1 day | +1.92% | ||
3 months | +5.79% | ||
6 months | +32.12% | ||
Current year | +13.20% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01/01/01 |
Director of Finance/CFO | 57 | 01/01/01 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01/01/01 |
C. Harris
BRD | Director/Board Member | 67 | 30/12/30 |
Ruby Chandy
BRD | Director/Board Member | 62 | 01/22/01 |
Date | Price | Change |
---|---|---|
13/24/13 | 585 | 0.00% |
14/24/14 | 585 | 0.00% |
13/24/13 | 585 | 0.00% |
10/24/10 | 585 | 0.00% |
09/24/09 | 585 | 0.00% |
End-of-day quote Lima, May 13, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.81% | 19TCr | |
+17.06% | 14TCr | |
+29.05% | 11TCr | |
+1.44% | 6.41TCr | |
+17.15% | 5.21TCr | |
+6.74% | 5.19TCr | |
+10.09% | 4.43TCr | |
+5.27% | 3.68TCr | |
+27.71% | 3.17TCr |
- Stock Market
- Equities
- TMO Stock
- TMO Stock